White Paper

What Does Pharma 4.0 Mean to Cell and Gene Therapy Drug Manufacturers?

Source: Apprentice

By Kelly Stewart

AI-Artificial Intelligence GettyImages-1244482898

Pharma 4.0 is the convergence of people, systems, and data within one singular network, creating a new era of digital transformation powered by advanced technologies such as artificial intelligence (AI) and machine learning. By collecting and analyzing data, investing in the right technologies, and developing the necessary skills and expertise, Pharma 4.0 can help CGT companies identify potential risks and take steps to mitigate them. CGT companies also need to develop the skills and expertise necessary to use these technologies effectively to reap the rewards. Find out about the benefits of Pharma 4.0 along with some challenges that need to be addressed.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online